News
-
Vox Royalty Sells I-80 Gold Offtake Stream
-
SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
-
Dateline Chairman Invests $1.95 million through Options Exercise
-
Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
-
Northern Dynasty Reports Oral Arguments Held
-
Cairn Homes Plc: Notice of H1 2026 Trading Update
-
JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
-
Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
-
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
-
Form 8.3 - The Vanguard Group, Inc.: Senior plc
-
Safran information
-
Information Safran
-
Rapport semestriel SIEHM au 30 avril 2026
-
Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
-
Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel